About Texas Immuno-oncology Biorepository

Every day, because of research, we get closer to detecting cancer earlier and treating it better. Through innovative new projects, like the Texas Immuno-Oncology Biorepository (TIOB), Baylor Scott & White Health looks to foster transformational immunology research that can lead to earlier diagnoses and novel immunotherapies.

Launched in September 2020, the TIOB aims to improve our understanding of how our immune system fights cancer by collecting biological samples, including blood, urine, tissue and stool, from actual patients across a range of genomic, racial and social backgrounds. Samples will be collected longitudinally over time, both during treatment and after treatment into long-term follow-up and studied by researchers to:

• Analyze how different cells and immune systems respond to cancer treatment
• Address why a cancer is resistant to treatment in some patients or why it returns in others
• Analyze if there are genomic, racial or environmental changes that occur across a diverse population of real-world Texans that can impact outcomes
• Learn how to improve patient response and survival rates

There is not a treatment or therapy available to fight cancer today that would exist if not for research and clinical trials, and philanthropy is crucial to these efforts.

Donate Now

For more information on how to support the TIOB, please contact Lynn Bohne at Lynn.Bohne@bswhealth.org.